Literature DB >> 16230390

Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes.

Weiming Ouyang1, Qian Ma, Jingxia Li, Dongyun Zhang, Zheng-Gang Liu, Anil K Rustgi, Chuanshu Huang.   

Abstract

Environmental and occupational exposure to arsenite is associated with an increased risk of human cancers, including skin, urinary bladder, and respiratory tract cancers. Although much evidence suggests that alterations in cell cycle machinery are implicated in the carcinogenic effect of arsenite, the molecular mechanisms underlying the cell cycle alterations are largely unknown. In the present study, we observed that exposure of human keratinocyte HaCat cells to arsenite resulted in the promotion of cell cycle progression, especially G(1)-S transition. Further studies found that arsenite exposure was able to induce cyclin D1 expression. The induction of cyclin D1 by arsenite required nuclear factor-kappaB (NF-kappaB) activation, because the inhibition of IkappaB phosphorylation by overexpression of the dominant-negative mutant, IKKbeta-KM, impaired arsenite-induced cyclin D1 expression and G1-S transition. The requirement of IkappaB kinase beta (IKKbeta) for cyclin D1 induction was further confirmed by the findings that arsenite-induced cyclin D1 expression was totally blocked in IKKbeta knockout (IKKbeta(-/-)) mouse embryo fibroblasts. In addition, knockdown of cyclin D1 expression using cyclin D1-specific small interference RNA significantly blocked arsenite-induced cell cycle progression in HaCat cells. Taken together, our results show that arsenite-induced cell cycle from G(1) to S phase transition is through IKKbeta/NF-kappaB/cyclin D1-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230390     DOI: 10.1158/0008-5472.CAN-05-0469

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.

Authors:  Changjun He; Xue-Pu Sun; Haiquan Qiao; Xian Jiang; Dongdong Wang; Xiangguo Jin; Xuesong Dong; Jizhou Wang; Hongchi Jiang; Xueying Sun
Journal:  Cancer Sci       Date:  2012-01-13       Impact factor: 6.716

2.  Genetic polymorphisms of NFκB1 -94 del/ins ATTG, NFκB1A 2758 A>G and SUMO rs237025 G>A in psoriasis.

Authors:  Abdullateef A Alzolibani; Ahmed Settin; Ahmed Ali Ahmed; Hisham Ismail; Noor Elhefni; Ahmad A Al Robaee
Journal:  Int J Health Sci (Qassim)       Date:  2015-01

3.  Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (ISO) on human bladder cancer cells.

Authors:  Guosong Jiang; Chao Huang; Jingxia Li; Haishan Huang; Jingjing Wang; Yawei Li; Fei Xie; Honglei Jin; Junlan Zhu; Chuanshu Huang
Journal:  Carcinogenesis       Date:  2018-03-08       Impact factor: 4.944

4.  Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.

Authors:  Weiming Ouyang; Dongyun Zhang; Jingxia Li; Udit N Verma; Max Costa; Chuanshu Huang
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

5.  IKK-β/NF-κB p65 mediates p27(Kip1) protein degradation in arsenite response.

Authors:  Wei Guo; Jinyi Liu; Jinlong Jian; Jingxia Li; Yu Wan; Chuanshu Huang
Journal:  Biochem Biophys Res Commun       Date:  2014-04-18       Impact factor: 3.575

6.  A novel role of IKKalpha in the mediation of UVB-induced G0/G1 cell cycle arrest response by suppressing Cyclin D1 expression.

Authors:  Lun Song; Wen Dong; Ming Gao; Jingxia Li; Meiru Hu; Ning Guo; Chuanshu Huang
Journal:  Biochim Biophys Acta       Date:  2010-01-15

7.  PI3K/Akt/JNK/c-Jun signaling pathway is a mediator for arsenite-induced cyclin D1 expression and cell growth in human bronchial epithelial cells.

Authors:  Jin Ding; Beifang Ning; Yi Huang; Dongyun Zhang; Jingxia Li; Chang-Yan Chen; Chuanshu Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

8.  c-Jun/AP-1 pathway-mediated cyclin D1 expression participates in low dose arsenite-induced transformation in mouse epidermal JB6 Cl41 cells.

Authors:  Dongyun Zhang; Jingxia Li; Jimin Gao; Chuanshu Huang
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-14       Impact factor: 4.219

9.  MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3.

Authors:  Heying Chu; Xudong Chen; Huaqi Wang; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Ping Li; Juan Li; Jingxia Chang; Guoqiang Zhao; Guojun Zhang
Journal:  Tumour Biol       Date:  2013-11-29

10.  Suberoylanilide hydroxamic acid (SAHA) inhibits EGF-induced cell transformation via reduction of cyclin D1 mRNA stability.

Authors:  Jingjie Zhang; Weiming Ouyang; Jingxia Li; Dongyun Zhang; Yonghui Yu; York Wang; Xuejun Li; Chuanshu Huang
Journal:  Toxicol Appl Pharmacol       Date:  2012-06-28       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.